Monitra Health bags US Patent for advanced wireless cardiac monitoring tech

The patented technology introduces a wireless patch-based cardiac monitoring device designed to enhance patient compliance and diagnostic accuracy

Hyderabad-based Monitra Healthcare announced the grant of its US Patent No. 12,109,029 B2, titled Wireless Cardiac Monitoring Device and Method to Measure and Transmit Cardiac Physiological Signals. The patent, issued by the United States Patent and Trademark Office marks a significant milestone in Monitra Health’s mission to revolutionise cardiac care through innovation.

The patented technology introduces a wireless patch-based cardiac monitoring device designed to enhance patient compliance and diagnostic accuracy. The patch automatically detects its orientation on the patient and optimally selects electrode pairs to ensure the highest quality signal transmission, eliminating errors from improper placement. The device processes bio-potential signals in real-time and wirelessly transmits physiological data to external systems for further analysis.
 
Ravi Bhogu, Inventor and Founder, Monitra Health, stated, “This patent underlines our commitment to delivering cutting-edge technology that empowers clinicians with more reliable and actionable cardiac data. By addressing these critical needs, this innovation represents a leap forward in cardiac monitoring. By addressing key challenges such as patient compliance and signal fidelity, this innovation represents a leap forward in cardiac monitoring.”
 
“Monitra Health’s innovation in cardiac monitoring aligns perfectly with our vision of supporting transformative solutions with global impact out of India. This patent highlights the company’s leadership in addressing critical unmet needs in cardiovascular diagnostics,” said Rajesh Sehgal, Managing Partner, Equanimity VC.
 
“The grant of this US patent is a testament to Monitra Health’s technological ingenuity and commitment to global excellence. We are pleased to support the company as it scales this innovation to reach patients and clinicians worldwide,” said Dhiraj Rajendran, Partner, Kotak Alternate Asset Managers.